|
Volumn 35, Issue 7, 2014, Pages 7233-7237
|
Serum transforming growth factor-beta 1 (TGF-β1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma
|
Author keywords
Melanoma; Serum; TGF 1
|
Indexed keywords
ANTINEOPLASTIC AGENT;
LACTATE DEHYDROGENASE;
TRANSFORMING GROWTH FACTOR BETA1;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER PROGNOSIS;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMAN;
LACTATE DEHYDROGENASE BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MELANOMA;
OVERALL SURVIVAL;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
TREATMENT RESPONSE;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
FEMALE;
HUMANS;
KAPLAN-MEIER ESTIMATE;
MALE;
MELANOMA;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
TRANSFORMING GROWTH FACTOR BETA1;
|
EID: 84904998264
PISSN: 10104283
EISSN: 14230380
Source Type: Journal
DOI: 10.1007/s13277-014-1984-z Document Type: Article |
Times cited : (21)
|
References (7)
|